Cleared Special

K183016 - SteriCap Mini Needle

K183016 is an FDA 510(k) clearance for SteriCap Mini Needle, manufactured by Ocujet, LLC. The device is a Class 2 General Hospital device with product code FMI cleared through the Special 510(k) pathway after a 188-day FDA review.

K183016 · Ocujet, LLC · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2019
Decision
188d
Days
Class 2
Risk

K183016 is an FDA 510(k) clearance for the SteriCap Mini Needle. Classified as Needle, Hypodermic, Single Lumen (product code FMI), Class II - Special Controls.

Submitted by Ocujet, LLC (Newport Beach, US). The FDA issued a Cleared decision on May 7, 2019 after a review of 188 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5570 - the FDA general hospital device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Ocujet, LLC devices

FDA 510(k) Submission Details - K183016

510(k) Number K183016 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 31, 2018
Decision Date May 07, 2019
Days to Decision 188 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d slower than avg
Panel avg: 129d · This submission: 188d
Pathway characteristics
Modification to existing cleared device.

FMI Device Classification - Class 2, Special Controls

Product Code FMI Needle, Hypodermic, Single Lumen
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMI Needle, Hypodermic, Single Lumen

All 271
Devices cleared under the same product code (FMI) and FDA review panel - the closest regulatory comparables to K183016.
K-Pack II Needle - 27G x 1/2” Extra Thin Wall, K-Pack II Needle - 27G x 1/2” Ultra Thin Wall, K-Pack II Needle - 30G x 1/2” Extra Thin Wall, K-Pack II Needle - 30G x 1/2” Ultra Thin Wall
K192057 · Terumo Europe N.V. · Oct 2019
NIO-I
K190538 · Waismed, Ltd. · Oct 2019
Dual-Safety Pen Needle
K191853 · Promisemed Hangzhou Meditech Co., Ltd. · Sep 2019
Adult Intraosseous Infusion Device
K182770 · Einstein Works, LLC · Apr 2019
Safety insulin needle for single use
K181447 · Berpu Medical Technology Co., Ltd. · Mar 2019
BD Vacutainer Eclipse UltraFill Blood Collection Needle
K181730 · Becton, Dickinson and Company · Mar 2019